Amneal Pharmaceuticals, Inc. (AMRX)
12.42
+0.18
(+1.51%)
USD |
NASDAQ |
May 21, 16:00
12.42
0.00 (0.00%)
After-Hours: 19:59
Amneal Pharmaceuticals Research and Development Expense (TTM) : 185.93M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viatris, Inc. | 965.80M |
| Pfizer Inc. | 10.52B |
| Crinetics Pharmaceuticals, Inc. | 351.77M |
| Prestige Consumer Healthcare, Inc. | -- |
| Amphastar Pharmaceuticals, Inc. | 77.22M |